MSFT 425.025 -0.9035% AAPL 220.43 0.8648% NVDA 115.85 1.4004% GOOGL 172.44 -0.1101% GOOG 174.27 -0.0573% AMZN 182.99 1.1945% META 460.09 -0.2558% AVGO 152.64 0.859% TSLA 224.8499 4.102% TSM 161.61 1.1327% LLY 823.56 -4.2238% V 257.56 1.3338% JPM 209.535 0.453% UNH 562.83 0.5502% NVO 129.31 -1.7401% WMT 70.206 -0.5581% LVMUY 143.15 0.9022% XOM 116.85 1.5999% LVMHF 714.04 0.4982% MA 436.96 1.0429%

Mystic Holdings Inc.

Healthcare US MSTH

0.055USD
-0.005(8.33%)

Last update at 2024-07-24T13:30:00Z

Day Range

0.060.06
LowHigh

52 Week Range

0.070.59
LowHigh

Fundamentals

  • Previous Close 0.06
  • Market Cap8.91M
  • Volume200
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.06308M
  • Revenue TTM12.36M
  • Revenue Per Share TTM0.11
  • Gross Profit TTM 2.37M
  • Diluted EPS TTM-

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax - - - - -
Minority interest - - - - -
Net income - - - - -
Selling general administrative - - - - -
Selling and marketing expenses - - - - -
Gross profit - - - - -
Reconciled depreciation - - - - -
Ebit -5.27057M -0.21851M -0.34570M -1.80720M -1.96969M
Ebitda - - - - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income - - - - -
Other operating expenses - - - - -
Interest expense - - 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.05M 1.62M 0.66M - 0.02M
Total revenue - - - - -
Total operating expenses - - - - -
Cost of revenue - - - - -
Total other income expense net - - - - -
Discontinued operations - - - - -
Net income from continuing ops - - - - -
Net income applicable to common shares -3.22171M -1.73291M -1.31666M -2.00464M -1.99047M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets - - - - -
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - -0.00000M - - -0.00000M
Total liab - - - - -
Total stockholder equity - - - - -
Deferred long term liab - - - - -
Other current liab 1.73M - 1.25M - 0.00000M
Common stock 0.15M 0.15M 0.14M 0.10M 0.00723M
Capital stock - - - - -
Retained earnings -12.88246M -9.66075M -7.82215M -6.50549M -4.50084M
Other liab 2.00M 0.58M - - -
Good will - - - - -
Other assets 9.48M 5.11M 1.50M 0.12M 0.12M
Cash - - - - -
Cash and equivalents - - - - -
Total current liabilities 3.30M 3.68M 3.69M 3.61M 4.47M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt - - - - -
Short long term debt total - - - - -
Other stockholder equity 0.00000M - - - -
Property plant equipment 5.37M 4.19M 4.17M 4.48M 3.65M
Total current assets 4.92M 6.95M 5.39M 1.80M 0.99M
Long term investments - - - - -
Net tangible assets 9.02M 10.00M -0.57713M -10.05509M 0.19M
Short term investments - - - - -
Net receivables 0.52M 0.46M 0.12M 0.26M 0.20M
Long term debt - - - - -
Inventory 4.36M 5.14M 2.53M 1.29M 0.78M
Accounts payable 1.57M 3.67M 1.83M 0.58M 0.64M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - - - -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.10000M -0.10000M -0.10000M -0.10000M -
Change to liabilities -2.10011M 1.42M 1.30M 0.14M 0.51M
Total cashflows from investing activities -1.85580M -0.43598M -13.05182M -9.61271M -0.40842M
Net borrowings -0.31819M -9.78282M -7.76268M 11.75M 0.53M
Total cash from financing activities 0.74M 1.46M 14.75M 11.85M 0.53M
Change to operating activities 1.24M -1.39585M 0.26M 0.14M 0.25M
Net income -3.22171M -1.73291M -1.31666M -2.00464M -1.99047M
Change in cash -1.30764M -1.39298M 2.49M 0.23M -0.60629M
Begin period cash flow - - - - -
End period cash flow - - - - -
Total cash from operating activities -0.18989M -2.41676M 0.79M -2.01039M -0.72852M
Issuance of capital stock - - - - -
Depreciation 1.75M 1.67M 1.64M 0.44M 0.31M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.78M -2.61222M -1.23412M -0.51585M 0.15M
Change to account receivables -0.06191M -0.34029M 0.14M -0.20701M 0.04M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -
Change to netincome 1.42M 0.58M 0.00000M 0.00000M -0.00000M
Capital expenditures 0.32M 0.44M 0.16M 1.19M 0.34M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - - - -
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow - - - - -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
MSTH
Mystic Holdings Inc.
-0.005 8.33% 0.06 - - - -
ZTS
Zoetis Inc
5.84 3.25% 185.50 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR
-0.06 0.18% 33.64 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien
-1.18 0.73% 160.95 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR
0.14 0.99% 13.71 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

Profile

Mystic Holdings, Inc., through its subsidiaries, engages in the cultivation, production, and wholesale of medical and recreational cannabis in Nevada, the United States. It offers cannabis flowers; edibles, such as gummies, brownie bites, cookies, caramels, rice crispies, and chocolate chip bars; concentrates and oils; pre-rolls and small bud batches; and cannabis vape products under the Qualcan, Lush, and Cosmic brands. The company also operates two recreational/medical retail dispensaries; and provides branding consulting services for third-party cannabis products. It serves state-licensed dispensaries. The company was founded in 2014 and is based in Las Vegas, Nevada.

Mystic Holdings Inc.

4145 Wagon Trail Avenue, Las Vegas, NV, United States, 89118

Key Executives

Name Title Year Born
Mr. Lorenzo Barracco Chairman & CEO 1973
Mr. Michael Cristalli Pres & Director 1971
Ms. Heather Cranny CFO, Treasurer, Sec. & Director 1985
Ms. Joanna DeFilippis COO & Director 1982

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.